WEIGAO GROUP (01066) announced its interim results, with profit attributable to shareholders of 774 million yuan, a year-on-year decrease of 23.23%.

WEIGAO GROUP (01066) announced its interim results for the six months ended June 30, 2026, with revenue of 6.849 billion yuan, a year-on-year increase of 3.08%. The profit attributable to the company's owners was 774 million yuan, a year-on-year decrease of 23.23%. Earnings per share were 0.17 yuan, and an interim dividend of 0.0854 yuan per share is proposed. During this period, the turnover from medical device products was approximately 3.364 billion yuan, an increase of 5.4% compared to the same period last year. Despite the growth in turnover, the operating profit saw a nearly 10% year-on-year decline due to price reductions for several core products implemented as part of centralized procurement policies starting in the third quarter of 2025. Nevertheless, the company managed to significantly enhance its operating profit in sequential terms by adjusting its product mix and optimizing marketing expenses, maintaining an operating profit margin of over 10%.